Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82


Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins.

Weston-Bell NJ, Hendriks D, Sugiyarto G, Bos NA, Kluin-Nelemans HC, Forconi F, Sahota SS.

Leukemia. 2013 Jan;27(1):241-5. doi: 10.1038/leu.2012.163. Epub 2012 Jun 18. No abstract available.


Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia.

Ewalt M, Nandula S, Phillips A, Alobeid B, Murty VV, Mansukhani MM, Bhagat G.

Hematol Oncol. 2012 Dec;30(4):190-3. doi: 10.1002/hon.1023. Epub 2011 Dec 22.


Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes.

Weston-Bell NJ, Forconi F, Kluin-Nelemans HC, Sahota SS.

PLoS One. 2014 Jan 30;9(1):e86556. doi: 10.1371/journal.pone.0086556. eCollection 2014.


Molecular detection of BRAF-V600E is superior to flow cytometry for disease evaluation in hairy cell leukaemia.

Rider T, Powell R, Gover R, Ansell R, Bastow S, Ghurye RR, Stewart H, Chevassut T.

Hematol Oncol. 2014 Sep;32(3):158-61. doi: 10.1002/hon.2097. Epub 2013 Oct 7. No abstract available.


Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia.

Tiacci E, Pucciarini A, Bigerna B, Pettirossi V, Strozzini F, Martelli MP, Tabarrini A, Drexler HG, Falini B.

Blood. 2012 May 31;119(22):5332-3. doi: 10.1182/blood-2011-12-400374. No abstract available.


Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.

Blombery PA, Wong SQ, Hewitt CA, Dobrovic A, Maxwell EL, Juneja S, Grigoriadis G, Westerman DA.

Haematologica. 2012 May;97(5):780-3. doi: 10.3324/haematol.2011.054874. Epub 2011 Dec 1.


Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.

Hockley SL, Morilla A, Else M, Dearden C, Catovsky D, Morgan GJ, Matutes E, Gonzalez D.

Leukemia. 2010 May;24(5):1084-6. doi: 10.1038/leu.2010.44. Epub 2010 Mar 18. No abstract available.


BRAF mutations in hairy-cell leukemia.

Pardanani A, Tefferi A.

N Engl J Med. 2011 Sep 8;365(10):961; author reply 961-2. doi: 10.1056/NEJMc1108130#SA2. No abstract available.


Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.

Mitsiades CS, Negri J, McMullan C, McMillin DW, Sozopoulos E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Poulaki V, Batt D, Mitsiades N.

Mol Cancer Ther. 2007 Mar;6(3):1070-8.


The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.

Arcaini L, Zibellini S, Boveri E, Riboni R, Rattotti S, Varettoni M, Guerrera ML, Lucioni M, Tenore A, Merli M, Rizzi S, Morello L, Cavalloni C, Da Vià MC, Paulli M, Cazzola M.

Blood. 2012 Jan 5;119(1):188-91. doi: 10.1182/blood-2011-08-368209. Epub 2011 Nov 9.


The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis.

Tadmor T, Tiacci E, Falini B, Polliack A.

Leuk Lymphoma. 2012 Dec;53(12):2339-40. doi: 10.3109/10428194.2012.706289. Epub 2012 Aug 13. No abstract available.


BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia.

Michonneau D, Kaltenbach S, Derrieux C, Trinquand A, Brouzes C, Gibault L, North MO, Delarue R, Varet B, Emile JF, Brousse N, Hermine O.

J Clin Oncol. 2014 Dec 10;32(35):e117-21. doi: 10.1200/JCO.2013.49.0078. Epub 2014 Feb 24. No abstract available.


The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.

Riesco-Eizaguirre G, Rodríguez I, De la Vieja A, Costamagna E, Carrasco N, Nistal M, Santisteban P.

Cancer Res. 2009 Nov 1;69(21):8317-25. doi: 10.1158/0008-5472.CAN-09-1248. Epub 2009 Oct 27.


Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.

Ouyang B, Knauf JA, Smith EP, Zhang L, Ramsey T, Yusuff N, Batt D, Fagin JA.

Clin Cancer Res. 2006 Mar 15;12(6):1785-93.


Absence of BRAF V600E mutation in hematologic malignancies excluding hairy-cell leukemia.

Ping N, Wang Q, Wang Q, Dong S, Wu L, Xue Y, Ruan C, Wu D, Chen S.

Leuk Lymphoma. 2012 Dec;53(12):2498-9. doi: 10.3109/10428194.2012.695777. Epub 2012 Jul 9. No abstract available.


A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?

Schlick K, Troch M, Placher-Sorko G, Faber V, Neureiter D, Berghoff AS, Preusser M, Greil R, Hopfinger G.

Ann Hematol. 2015 Feb;94(2):345-6. doi: 10.1007/s00277-014-2162-5. Epub 2014 Jul 24. No abstract available.


High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies.

Boyd EM, Bench AJ, van 't Veer MB, Wright P, Bloxham DM, Follows GA, Scott MA.

Br J Haematol. 2011 Dec;155(5):609-12. doi: 10.1111/j.1365-2141.2011.08868.x. Epub 2011 Sep 13.


BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia.

Raess PW, Mintzer D, Husson M, Nakashima MO, Morrissette JJ, Daber R, Bagg A.

Blood. 2013 Oct 24;122(17):3084-5. doi: 10.1182/blood-2013-07-513523. No abstract available.


Discrepant results for BRAF V600E mutation among different specimens in a case of hairy cell leukemia.

Moon HW, Hur M, Han SH, Yun YM, Kim SY.

Ann Lab Med. 2013 Jul;33(4):300-3. doi: 10.3343/alm.2013.33.4.300. Epub 2013 Jun 24. No abstract available.


G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.

Mapara MY, Bommert K, Bargou RC, Leng C, Beck C, Ludwig WD, Gierschik P, Dörken B.

Blood. 1995 Apr 1;85(7):1836-42.

Supplemental Content

Support Center